These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9428564)

  • 1. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
    Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ
    Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laudanosine, an atracurium and cisatracurium metabolite.
    Fodale V; Santamaria LB
    Eur J Anaesthesiol; 2002 Jul; 19(7):466-73. PubMed ID: 12113608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.
    Parker CJ; Jones JE; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.
    Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC
    Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage.
    Tassonyi E; Fathi M; Hughes GJ; Chiodini F; Bertrand D; Muller D; Fuchs-Buder T
    Acta Anaesthesiol Scand; 2002 Nov; 46(10):1236-41. PubMed ID: 12421196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
    Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P
    Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients.
    Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ
    Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
    Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of atracurium and laudanosine in the elderly.
    Kent AP; Parker CJ; Hunter JM
    Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.
    Nigrovic V; Gaspari J; Banoub M
    Eur J Clin Pharmacol; 1996; 49(4):325-32. PubMed ID: 8857080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
    Parker CJ; Hunter JM
    Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolonged use of atracurium in a patient with tetanus.
    Peat SJ; Potter DR; Hunter JM
    Anaesthesia; 1988 Nov; 43(11):962-3. PubMed ID: 3213921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.